Insider Buy/Sell Details for the Biotechnology Industry — Last 7 Days
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (231)
MeiraGTx Holdings plc (MGTX)
Forbes Alexandria — Director
Shares
62,000
Price
$13.86
Total Value
$859.32K
Shares Held After
1,325,695
% of Holdings
4.5%
Roivant Sciences Ltd. (ROIV)
Sukhatme Mayukh — Director
Shares
31,801
Price
$37.18
Total Value
$1.18M
Shares Held After
18,630,739
% of Holdings
0.2%
Roivant Sciences Ltd. (ROIV)
Sukhatme Mayukh — Director
Shares
105,141
Price
$36.59
Total Value
$3.85M
Shares Held After
18,630,739
% of Holdings
0.6%
Invivyd, Inc. (IVVD)
Andersen Jill — Chief Legal Officer, Secretary
Shares
30,706
Price
$0.84
Total Value
$25.88K
Shares Held After
283,774
% of Holdings
9.8%
Stoke Therapeutics, Inc. (STOK)
Allan Jonathan — GENERAL COUNSEL&CORP SEC
Shares
145
Price
$32.47
Total Value
$4.71K
Shares Held After
21,225
% of Holdings
0.7%
Stoke Therapeutics, Inc. (STOK)
Allan Jonathan — GENERAL COUNSEL&CORP SEC
Shares
2,716
Price
$32.01
Total Value
$86.93K
Shares Held After
21,370
% of Holdings
11.3%
Invivyd, Inc. (IVVD)
Duke William E. — Chief Financial Officer
Shares
18,425
Price
$0.84
Total Value
$15.53K
Shares Held After
168,937
% of Holdings
9.8%
Invivyd, Inc. (IVVD)
Lee Timothy Edward — Chief Commercial Officer
Shares
18,425
Price
$0.84
Total Value
$15.53K
Shares Held After
178,937
% of Holdings
9.3%
Invivyd, Inc. (IVVD)
Allen Robert D. III — Chief Scientific Officer
Shares
17,043
Price
$0.84
Total Value
$14.37K
Shares Held After
178,765
% of Holdings
8.7%
Invivyd, Inc. (IVVD)
Green Julie — Chief Human Resources Officer
Shares
18,425
Price
$0.84
Total Value
$15.53K
Shares Held After
168,937
% of Holdings
9.8%
Stoke Therapeutics, Inc. (STOK)
Ticho Barry — CHIEF MEDICAL OFFICER
Shares
242
Price
$32.47
Total Value
$7.86K
Shares Held After
25,655
% of Holdings
0.9%
Stoke Therapeutics, Inc. (STOK)
Ticho Barry — CHIEF MEDICAL OFFICER
Shares
4,525
Price
$32.01
Total Value
$144.83K
Shares Held After
25,897
% of Holdings
14.9%
Stoke Therapeutics, Inc. (STOK)
Kaye Edward M. MD — Director
Shares
637
Price
$32.47
Total Value
$20.68K
Shares Held After
124,557
% of Holdings
0.5%
Stoke Therapeutics, Inc. (STOK)
Kaye Edward M. MD — Director
Shares
11,930
Price
$32.01
Total Value
$381.85K
Shares Held After
125,194
% of Holdings
8.7%
EyePoint, Inc. (EYPT)
Zaderej Karen L. — Director
Shares
10,600
Price
$4.93
Total Value
$52.26K
Shares Held After
49,100
% of Holdings
21.6%
CYTOKINETICS INC (CYTK)
Malik Fady Ibraham — EVP Research&Development
Shares
3,500
Price
$75.82
Total Value
$265.37K
Shares Held After
153,902
% of Holdings
2.2%
Verrica Pharmaceuticals Inc. (VRCA)
Rosenberg Noah L. — CMO
Shares
2,030
Price
$4.92
Total Value
$9.99K
Shares Held After
8,587
% of Holdings
23.6%
Verrica Pharmaceuticals Inc. (VRCA)
Kirby John J. — Interim CFO
Shares
5,000
Price
$4.93
Total Value
$24.65K
Shares Held After
23,962
% of Holdings
20.9%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
Heshmatpour Amir F — Director
Shares
9,000
Price
$5.54
Total Value
$49.86K
Shares Held After
3,096,000
% of Holdings
0.3%
AbCellera Biologics Inc. (ABCL)
Montalbano John S. — Director
Shares
10,000
Price
$11.03
Total Value
$110.30K
Shares Held After
251,000
% of Holdings
4.0%
Roivant Sciences Ltd. (ROIV)
Sukhatme Mayukh — Director
Shares
284,707
Price
$36.25
Total Value
$10.32M
Shares Held After
18,630,739
% of Holdings
1.5%
Invivyd, Inc. (IVVD)
Andersen Jill — Chief Legal Officer, Secretary
Shares
37,256
Price
$0.72
Total Value
$26.90K
Shares Held After
314,480
% of Holdings
10.6%
Invivyd, Inc. (IVVD)
Duke William E. — Chief Financial Officer
Shares
22,355
Price
$0.72
Total Value
$16.14K
Shares Held After
187,362
% of Holdings
10.7%
Invivyd, Inc. (IVVD)
Lee Timothy Edward — Chief Commercial Officer
Shares
22,355
Price
$0.72
Total Value
$16.14K
Shares Held After
197,362
% of Holdings
10.2%
Invivyd, Inc. (IVVD)
Allen Robert D. III — Chief Scientific Officer
Shares
20,679
Price
$0.72
Total Value
$14.93K
Shares Held After
195,808
% of Holdings
9.6%
Invivyd, Inc. (IVVD)
Green Julie — Chief Human Resources Officer
Shares
22,355
Price
$0.72
Total Value
$16.14K
Shares Held After
187,362
% of Holdings
10.7%
Disc Medicine, Inc. (IRON)
Quisel John D — Director
Shares
11,888
Price
$79.84
Total Value
$949.16K
Shares Held After
226,064
% of Holdings
5.0%
Disc Medicine, Inc. (IRON)
Quisel John D — Director
Shares
12,712
Price
$79.20
Total Value
$1.01M
Shares Held After
237,952
% of Holdings
5.1%
Disc Medicine, Inc. (IRON)
Quisel John D — Director
Shares
8,400
Price
$78.11
Total Value
$656.09K
Shares Held After
250,664
% of Holdings
3.2%
Seres Therapeutics, Inc. (MCRB)
DesRosier Thomas — EVP and Chief Legal Officer
Shares
82
Price
$4.55
Total Value
$373.10
Shares Held After
8,117
% of Holdings
1.0%
Seres Therapeutics, Inc. (MCRB)
Brady Kelly — EVP, Chief Operating Officer
Shares
64
Price
$4.55
Total Value
$291.20
Shares Held After
8,679
% of Holdings
0.7%
ALX ONCOLOGY HOLDINGS INC (ALXO)
Wong Shelly — SVP, FINANCE AND CAO
Shares
573
Price
$1.93
Total Value
$1.11K
Shares Held After
87,828
% of Holdings
0.6%
ALX ONCOLOGY HOLDINGS INC (ALXO)
Lettmann Jason — Director
Shares
2,230
Price
$1.93
Total Value
$4.30K
Shares Held After
294,379
% of Holdings
0.8%
Seres Therapeutics, Inc. (MCRB)
Henn Matthew R — President and Chief Scientific Officer
Shares
81
Price
$4.55
Total Value
$368.55
Shares Held After
7,995
% of Holdings
1.0%
Seres Therapeutics, Inc. (MCRB)
Shaff Eric D. — Director
Shares
263
Price
$4.55
Total Value
$1.20K
Shares Held After
12,499
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,683
Price
$508.17
Total Value
$855.25K
Shares Held After
324,443
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,298
Price
$507.43
Total Value
$1.67M
Shares Held After
326,126
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,521
Price
$506.35
Total Value
$1.28M
Shares Held After
329,424
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,238
Price
$505.36
Total Value
$625.64K
Shares Held After
331,945
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$504.21
Total Value
$60.50K
Shares Held After
333,183
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
427
Price
$502.18
Total Value
$214.43K
Shares Held After
333,303
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
213
Price
$501.06
Total Value
$106.73K
Shares Held After
333,730
% of Holdings
0.1%
Verrica Pharmaceuticals Inc. (VRCA)
Zawitz David — Chief Operating Officer
Shares
6,000
Price
$4.98
Total Value
$29.88K
Shares Held After
27,000
% of Holdings
22.2%
Verrica Pharmaceuticals Inc. (VRCA)
Rosenberg Noah L. — CMO
Shares
4,200
Price
$4.91
Total Value
$20.62K
Shares Held After
6,557
% of Holdings
64.1%
Verrica Pharmaceuticals Inc. (VRCA)
Rieger Jayson — Director
Shares
5,000
Price
$4.91
Total Value
$24.55K
Shares Held After
207,593
% of Holdings
2.4%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
CHEN THOMAS C — Director
Shares
2,472
Price
$4.04
Total Value
$10.00K
Shares Held After
583,531
% of Holdings
0.4%
Relay Therapeutics, Inc. (RLAY)
Patel Sanjiv — Director
Shares
48,199
Price
$20.33
Total Value
$979.89K
Shares Held After
567,699
% of Holdings
7.8%
CORCEPT THERAPEUTICS INC (CORT)
Robb Gary Charles — Chief Business Officer
Shares
10,000
Price
$116.26
Total Value
$1.16M
Shares Held After
39,716
% of Holdings
20.1%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
5,400
Price
$0.93
Total Value
$5.02K
Shares Held After
381,115
% of Holdings
1.4%
Tenaya Therapeutics, Inc. (TNYA)
Ali Faraz — Director
Shares
7,406
Price
$0.71
Total Value
$5.26K
Shares Held After
417,782
% of Holdings
1.7%
Showing 1–50 of 231 transactions (page 1 of 5)